Trial Profile
A Phase III, Randomised, International Trial Comparing mFOLFIRINOX Triplet Chemotherapy to mFOLFOX for High-risk Stage III Colon Cancer in Adjuvant Setting
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colon cancer
- Focus Therapeutic Use
- Acronyms IROCAS
- 30 Aug 2023 Status changed from recruiting to active, no longer recruiting.
- 20 Jul 2021 Planned End Date changed from 1 Jun 2026 to 1 Jun 2027.
- 24 Jun 2020 Status changed from suspended to recruiting.